ORPHA:93622
Dent disease type 1
Query health: suspect — Only one of 2 strategies returned hits (phrase).
Publications
104
64.7th percentile
Trials
0
Interventional, condition-specific
Researchers
631
Distinct authors in sample
Gene link
CLCN5
Definitive
Readiness
2/6
Stages with a signal
Clinical definition (Orphanet)
A rare X-linked monogenic renal tubular disease, characterized by manifestations of complex proximal tubule dysfunction with low-molecular-weight (LMW) proteinuria, hypercalciuria, nephrolithiasis, nephrocalcinosis, and renal failure. Extra-renal involvement is absent.
How rare: How common this is has not been clearly measured.
Cross-references
Joined from Mondo / Orphanet. MeSH labels may enter searches; UMLS / OMIM / NCIT are stored for reference.
- MONDO:0010225
- OMIM:300009
- UMLS:C1848336
Additional Mondo synonyms (4)
CLCN5 Dent disease · Dent disease caused by mutation in CLCN5 · dent disease 1, X-linked recessive · nephrolithiasis type 1
Research stages
Trial readiness signals
Where this condition sits on an open-data research pipeline — not how close a treatment is, and not medical advice. Empty stages often mean “not in these databases under this Mondo ID,” not “impossible.”
2/6 stages with a signal
No matched interventional trial; the gene is known and literature exists — preclinical or natural-history work may still be the practical next step.
- Gene identifiedPresent
Definitive — CLCN5
- LiteraturePresent
104 matched papers (90 in last 10 years) Source
- Phenotype characterisedNot checked
Not yet enriched from Monarch / HPO
- Animal modelNot checked
Not yet enriched from Monarch / Alliance
- Orphan designationNot checked
FDA/EMA orphan-drug designation not enriched yet
- Interventional trialNot found
No matched interventional trial under our ClinicalTrials.gov rules
Biology
Genes and phenotypes
Gene–disease validity from GenCC, plus phenotypes and animal models joined from Monarch Initiative via Mondo ID — not a clinical diagnosis aid.
Do we know what causes it?
Yes — we know a specific gene responsible (CLCN5).
GenCC classification: Definitive.
Phenotypes (Monarch / HPO)
Not enriched in this build — Monarch phenotype joins were not run for this record.
Animal models (Monarch / Alliance)
Not enriched in this build.
Literature
Is anyone studying this?
104
104 papers have ever been published on this condition (under this name). For scale, breast cancer has over 700,000. Median papers in the last 10 years for a rare disease in this dataset (publications denominator n=5449) is 41.
104 papers since the earliest indexed year in this search — median last-10-year count for a rare disease in this dataset is 41 (publications denominator n=5449).
90 in the last 10 years · high confidence · 64.7th percentile (publications denominator)
Phrase hits: 104 · MeSH hits: 0
Who's working on it?
631
Distinct author names in 104 sampled papers — named people below.
Who's working on it?
No interventional trial matched this name; these authors publish on it in the sampled literature — a practical starting point for contact.
- 01Lieske JC8 papers · 2026
Division of Nephrology and Hypertension, Mayo Clinic College of Medicine, Rochester, MN, USA; O'Brien Urology Research Center, Mayo Clinic College of Medicine, Rochester, MN, USA; Department of Laboratory Medicine and Pathology, Mayo Clinic College of Medicine, Rochester, MN, USA.
Papers in Europe PMC - 02Anglani F6 papers · 2024
Division of Nephrology, Department of Medicine, Laboratory of Histomorphology and Molecular Biology of the Kidney, University of Padua, Padua, Italy.
Papers in Europe PMC - 03Harris PC6 papers · 2026
Division of Nephrology and Hypertension, Mayo Clinic College of Medicine, Rochester, MN, USA; Department of Biochemistry and Molecular Biology, Mayo Clinic College of Medicine, Rochester, MN, USA.
Papers in Europe PMC - 04Cheong HI5 papers · 2026
Department of Pediatrics, Seoul National University College of Medicine, Seoul 03080, Korea.
Papers in Europe PMC - 05Gianesello L5 papers · 2023
Division of Nephrology, Department of Medicine, Laboratory of Histomorphology and Molecular Biology of the Kidney, University of Padua, Padua, Italy.
Papers in Europe PMC - 06Del Prete D4 papers · 2023
Kidney Histomorphology and Molecular Biology Laboratory, Clinical Nephrology Unit, Department of Medicine - DIMED, University of Padua, Padua, Italy. Electronic address: dorella.delprete@unipd.it.
Papers in Europe PMC - 07Lu B4 papers · 2026
Wake Forest Institute for Regenerative Medicine, Wake Forest University School of Medicine, Winston-Salem, NC, USA. blu@wakehealth.edu.
Papers in Europe PMC - 08Priante G4 papers · 2024
Kidney Histomorphology and Molecular Biology Laboratory, Clinical Nephrology Unit, Department of Medicine - DIMED, University of Padua, Padua, Italy. Electronic address: giovanna.priante@unipd.it.
Papers in Europe PMC - 09Romero MF4 papers · 2026
Physiology and Biomedical Engineering, Mayo Clinic College of Medicine & Science, 200 First Street SW, Rochester, MN 55905, USA; Nephrology and Hypertension, Mayo Clinic College of Medicine and Science, 200 First Street SW, Rochester, MN 55905, USA. Electronic address: Romero.Michael@mayo.edu.
Papers in Europe PMC - 10Thakker RV4 papers · 2022
Academic Endocrine Unit, Radcliffe Department of Medicine,, University of Oxford, Oxford, UK.
Papers in Europe PMC
Clinical research
Is a treatment being tested?
0
interventional trials for this specific condition
No interventional trial testing a treatment matched this specific condition name on ClinicalTrials.gov (observational studies and pan-disease registries are listed separately when present).
Data as of 27 July 2026
No matched interventional trials. This is true for 73% of diseases in the trials denominator (5114 of 7003). Here are the researchers publishing on it.
high confidence · 36.5th percentile (trials denominator)
Recruiting interventional trials
From the matched ClinicalTrials.gov set
No interventional trial testing a treatment was found for this specific condition name on ClinicalTrials.gov.
See who's working on it — people publishing on this disease are often the practical next contact when no trial is listed.
Where to find support
We do not yet link condition-specific patient organisations. These umbrella groups support undiagnosed and ultra-rare families:
India — NPRD
Last verified 2026-07-26This ORPHAcode is not on our curated NPRD list (direct or Mondo-parent match). That does not decide clinical eligibility; families in India should ask a notified Centre of Excellence about current coverage.
Hand-curated for this project. ORPHAcode mappings are best-effort and may be incomplete or imprecise for umbrella categories. Parent (Mondo) matches mean the policy lists a broader category — confirm eligibility with a Centre of Excellence. Financial entitlements summarised from public policy statements and may change. This is not official government guidance.
How we counted this
Europe PMC query (preferred label + any corrected label + Orphanet and Mondo exact synonyms, stoplisted; unioned with resolved MeSH labels when available). UMLS / OMIM / NCIT cross-references are stored on the overview but are not added to the query string.
"Dent disease type 1" OR "CLCN5 Dent disease" OR "dent disease 1, X-linked recessive" OR "nephrolithiasis type 1"
ClinicalTrials.gov query (quoted phrases + MeSH via query.cond, plus recall-expansion terms when used):
"Dent disease type 1" OR "CLCN5 Dent disease" OR "dent disease 1, X-linked recessive" OR "nephrolithiasis type 1" OR "CLCN5"
Recall-expansion terms: CLCN5
Study-type breakdown: 0 interventional · 0 observational · 0 expanded access. Only interventional studies enter the trial headline.
Query health: suspect — strategies attempted: phrase, recall-expansion; with hits: phrase
Run this search on ClinicalTrials.gov
Synonyms dropped by stoplist: Dent disease caused by mutation in CLCN5
Confidence reasoning
- Preferred label is multi-word and distinctive
- No synonyms dropped by stoplist
- No label/synonym collisions with other diseases in this corpus
Ingested 2026-07-27T04:29:42.500Z